GATA2 and acute myeloid leukemia: A frequent co-mutation in biallelic CEBPa AML is represented by heterozygous GATA2 mutations in Zinc Finger 1 (ZnF1) [143,144,145], which are thought to reduce p30/p30 transcriptional activation [143].